Back to Trials
NCT07619391NARecruiting

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Ohio State University Comprehensive Cancer Center

Start Date

3/10/2026

Completion Date

12/31/2027

Summary

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Detailed Description

PRIMARY OBJECTIVE: I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment. OUTLINE: Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Adults ≥ 18 years old * Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days * English speaking * Access to a smartphone (Android or iOS) Exclusion Criteria: * Prisoners * Patients undergoing cancer surveillance

Interventions

OTHER

Electronic Health Record Review

BEHAVIORAL

Smartphone Application-based Intervention

OTHER

Survey Administration

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pancreatic Adenocarcinoma

Locations

Ohio State University Comprehensive Cancer Center

Columbus, Ohio 43210

United States